newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics to Participate in Upcoming March Investor Conferences

  • DiaMedica Therapeutics Inc. (NASDAQ: DMAC) announced that management will attend three investment bank conferences in March 2026.
  • CEO Rick Pauls & CMO Julie Krop, M.D. will participate in a fireside chat at the TD Cowen 46th Annual Healthcare Conference in Boston on Monday, March 2, 2026, at 11:50 a.m. ET.
  • CEO Rick Pauls will hold a fireside chat at the Barclays 28th Annual Global Healthcare Conference in Miami on Wednesday, March 10, 2026, at 10:00 a.m. ET.
  • CEO Rick Pauls will deliver a company presentation at the Leerink Partners Global Healthcare Conference in Miami on Wednesday, March 11, 2026, at 3:00 p.m. ET.
  • Investors may contact their conference representative to arrange 1x1 meetings with management.
  • DiaMedica is a clinical-stage biopharmaceutical company focused on preeclampsia, fetal growth restriction, & acute ischemic stroke.
  • The company's lead candidate, DM199, is the first recombinant form of the KLK1 protein for treating acute ischemic stroke, preeclampsia, & other vascular diseases.
  • Scott Kellen serves as Chief Financial Officer, while Mike Moyer handles investor inquiries & Madelin Hawtin serves as the media contact.